COMP <GO>
TAYD vs TMO // ALTMAN Z-SCORE & DEBT/EQUITY
Taylor Devices Inc. (NASDAQ) VS. Thermo Fisher Scientific Inc (NYSE) • 15-METRIC TALLY: TAYD 5
— TMO 6
■ METRIC PARITY
LAST: $56.87 (-0.45%) • MKT CAP: $183.7M
balance-sheet
—
LAST: $709.18 (+0.71%) • MKT CAP: $262.22B
balance-sheet
4.50
15-METRIC INSTITUTIONAL SIDE-BY-SIDE SCORECARD (TAYD VS. TMO)
EMERALD CELL = QUANTITATIVE EDGE
| INSTITUTIONAL METRIC | TAYD | TMO | SPREAD (A - B) | ADVANTAGE | DEDICATED URL |
|---|---|---|---|---|---|
| Gross Profit Margin | 44.10% | — | — | TIE | /gross-margins <GO> |
| Return on Invested Capital (ROIC) | 8.90% | 9.30% | -0.40 | TMO | /roic <GO> |
| EV/EBITDA & P/E Valuation | 19.8x | 30.4x | -10.60 | TAYD | /valuation <GO> |
| Free Cash Flow Yield | 2.66% | 2.40% | +0.26 | TAYD | /fcf-yield <GO> |
| Operating Margin | 17.60% | 17.40% | +0.20 | TAYD | /operating-margins <GO> |
| Net Profit Margin | 20.60% | 15.10% | +5.50 | TAYD | /net-margins <GO> |
| Revenue Growth (YoY) | -10.00% | 3.90% | -13.90 | TMO | /revenue-growth <GO> |
| Dividend Yield & FCF Payout Safety | 0.00% | 0.24% | -0.24 | TMO | /dividend-safety <GO> |
| Altman Z-Score & Debt/Equity ACTIVE | — | 4.50 | — | TIE | /balance-sheet <GO> |
| Piotroski F-Score Quality | 5/9 | 8/9 | -3.00 | TMO | /piotroski-score <GO> |
| Options Implied Move & Put/Call Skew | — | — | — | TIE | /options-implied-move <GO> |
| RSI-14 & 200D SMA Momentum | 48.6 | 62.9 | -14.30 | TMO | /rsi-technicals <GO> |
| 10Y Yield & FRED Macro Beta | — | 0.94 | — | TIE | /macro-sensitivity <GO> |
| Forward P/E Multiple | 19.9x | 36.3x | -16.40 | TAYD | /forward-pe <GO> |
| Enterprise Scale & Market Cap | $183.7M | $262.22B | -$262.03B | TMO | /market-cap <GO> |
5-YEAR HISTORICAL XBRL REVENUE & MARGIN TRAJECTORY SEC FORM 10-K FY
| FISCAL YEAR | TAYD REV | TMO REV | TAYD GROSS % | TMO GROSS % | TAYD FCF | TMO FCF |
|---|---|---|---|---|---|---|
| FY 2025 | $41.6M | $44.56B | 44.1% | — | $4.9M | $6.29B |
| FY 2024 | $46.3M | $42.88B | 46.4% | — | $4.9M | $7.27B |
| FY 2023 | $44.6M | $42.86B | — | — | $13.2M | $6.48B |
FRED MACRO REGIME CORRELATION COMPARISON PEARSON r
TAYD // BETA —
TMO // BETA 0.94